Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047068 · ClinicalTrials.gov registry record
OCS Heart Perfusion Post-Approval Registry
A clinical trial of Transplant, sponsored by TransMedics.
- Active
- Registry status
- 350
- Enrollment target
- 20
- Study locations
NCT05047068: Active study of Transplant, sponsored by TransMedics.
NCT05047068 is a study of Transplant that is active but no longer recruiting, run by TransMedics. The registered enrollment target is 350 participants, above the 177-participant average among 5 other Transplant trials with a reported enrollment target (98% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05047068, a study of Transplant, is active but no longer recruiting, sponsored by TransMedics.
- ACTIVE NOT RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.
Primary Outcome
Patient survival at one-year post-heart transplant.
Conditions Studied
Interventions
- DEVICE OCS Heart System
Study Locations (20)
California
- Cedars Sinai - Los Angeles
- Stanford University - Palo Alto
- University of California San Francisco - San Francisco
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Minnesota
- Minneapolis Heart Institute - Minneapolis
- University of Minnesota - Minneapolis
- Mayo Clinic Rochester - Rochester
New York
- Columbia University Irving Medical Center/ New York Presbyterian Hospital - New York
- Montefiore - The Bronx
- Westchester Medical Center - Valhalla
Florida
- Mayo Clinic Florida - Jacksonville
- Tampa General Hospital - Tampa
Connecticut
- Yale New Haven Hospital - New Haven
Georgia
- Emory University Hospital - Atlanta
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2029-12 |
What the registry record for NCT05047068 still lists
NCT05047068 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 177-participant average among 5 other Transplant trials with a reported enrollment target (98% higher).
The record links to 1 condition, with Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Heart System is the first listed.
NCT05047068 names 20 study sites across 11 states, led by California, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05047068 about?
NCT05047068 is a clinical study titled "OCS Heart Perfusion Post-Approval Registry". The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.
What is the current status of trial NCT05047068?
This trial is currently active not recruiting. The enrollment target is 350 participants. The study started on 2021-09-13. Estimated completion is 2029-12.
What conditions does trial NCT05047068 study?
This clinical trial studies the following conditions: Transplant.
What interventions are being tested in trial NCT05047068?
The interventions under investigation include: OCS Heart System (DEVICE).
Who is sponsoring clinical trial NCT05047068?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05047068 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
RECRUITING
-
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
RECRUITING
-
Optimizing Y90 Therapy for Radiation Lobectomy
RECRUITING
-
Concomitant Renal and Urinary Bladder Allograft Transplantation
RECRUITING · Early Phase 1
-
Xofluza-Wearables Feasibility-Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI